Martha Greiner

1.1k total citations
10 papers, 865 citations indexed

About

Martha Greiner is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Martha Greiner has authored 10 papers receiving a total of 865 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 5 papers in Pediatrics, Perinatology and Child Health and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Martha Greiner's work include Epilepsy research and treatment (5 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 papers). Martha Greiner is often cited by papers focused on Epilepsy research and treatment (5 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 papers). Martha Greiner collaborates with scholars based in United States, Canada and Germany. Martha Greiner's co-authors include Mark Pierce, Elizabeth A. Garofalo, Atul C. Pande, R. Bruce Lydiard, Basim M. Uthman, Ahmad Beydoun, Robert E. Pyke, C. Barr Taylor, Mark H. Pollack and Jerri G. Crockatt and has published in prestigious journals such as Neurology, Biological Psychiatry and Epilepsy Research.

In The Last Decade

Martha Greiner

10 papers receiving 812 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martha Greiner United States 9 487 361 339 139 126 10 865
Jerri G. Crockatt United States 7 529 1.1× 261 0.7× 192 0.6× 111 0.8× 88 0.7× 9 1.0k
C. Albano Italy 14 361 0.7× 164 0.5× 304 0.9× 102 0.7× 97 0.8× 36 743
Hrvoje Hečimović Croatia 12 541 1.1× 360 1.0× 307 0.9× 113 0.8× 153 1.2× 29 807
T. Kolakowska United Kingdom 18 905 1.9× 82 0.2× 172 0.5× 78 0.6× 84 0.7× 30 1.2k
Post Rm United States 14 381 0.8× 108 0.3× 235 0.7× 93 0.7× 38 0.3× 29 731
Yoshiteru Takekita Japan 16 321 0.7× 90 0.2× 201 0.6× 211 1.5× 46 0.4× 48 845
Sean W. Flynn Canada 11 219 0.4× 84 0.2× 245 0.7× 165 1.2× 52 0.4× 17 907
Jeffrey Kraft United States 9 247 0.5× 68 0.2× 317 0.9× 262 1.9× 57 0.5× 13 987
Christian Landvogt Germany 15 300 0.6× 55 0.2× 375 1.1× 189 1.4× 200 1.6× 24 968
Karuna Jayathilake United States 17 537 1.1× 44 0.1× 218 0.6× 126 0.9× 108 0.9× 24 812

Countries citing papers authored by Martha Greiner

Since Specialization
Citations

This map shows the geographic impact of Martha Greiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martha Greiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martha Greiner more than expected).

Fields of papers citing papers by Martha Greiner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martha Greiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martha Greiner. The network helps show where Martha Greiner may publish in the future.

Co-authorship network of co-authors of Martha Greiner

This figure shows the co-authorship network connecting the top 25 collaborators of Martha Greiner. A scholar is included among the top collaborators of Martha Greiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martha Greiner. Martha Greiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Beydoun, Ahmad, Basim M. Uthman, Alan R. Kugler, et al.. (2005). Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy. Neurology. 64(3). 475–480. 156 indexed citations
2.
Pande, Atul C., Mark H. Pollack, Jerri G. Crockatt, et al.. (2000). Placebo-Controlled Study of Gabapentin Treatment of Panic Disorder. Journal of Clinical Psychopharmacology. 20(4). 467–471. 212 indexed citations
3.
DeToledo, John C., R. Eugene Ramsay, Merredith R. Lowe, Martha Greiner, & Elizabeth A. Garofalo. (2000). Increased Seizures After Discontinuing Carbamazepine: Results From the Gabapentin Monotherapy Trial. Therapeutic Drug Monitoring. 22(6). 753–756. 6 indexed citations
4.
Pande, Atul C., et al.. (1999). Placebo-controlled trial of the CCK-B antagonist, CI-988, in panic disorder. Biological Psychiatry. 46(6). 860–862. 38 indexed citations
5.
Dodrill, Carl B., et al.. (1999). Cognitive abilities and adjustment with gabapentin: results of a multisite study. Epilepsy Research. 35(2). 109–121. 46 indexed citations
6.
Chadwick, David, Henning Anhut, Martha Greiner, et al.. (1998). A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. Neurology. 51(5). 1282–1288. 160 indexed citations
7.
8.
Pyke, Robert E., et al.. (1996). Analgesic Efficacy of the κ-Receptor Agonist, Enadoline, in Dental Surgery Pain. Clinical Neuropharmacology. 19(1). 92–97. 49 indexed citations
9.
Pande, Atul C., et al.. (1996). Analgesic Efficacy of Enadoline Versus Placebo or Morphine in Postsurgical Pain. Clinical Neuropharmacology. 19(5). 451–456. 65 indexed citations
10.
Pyke, Robert E., Neal R. Cutler, Edward E. Schweizer, et al.. (1995). A Double-Blind, Placebo-Controlled Study of a CCK-B Receptor Antagonist, CI-988, in Patients With Generalized Anxiety Disorder. Journal of Clinical Psychopharmacology. 15(6). 428–434. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jerri G. Crockatt Breakdown of academic impact, for papers by C. Albano Breakdown of academic impact, for papers by Hrvoje Hečimović Breakdown of academic impact, for papers by T. Kolakowska Breakdown of academic impact, for papers by Post Rm Breakdown of academic impact, for papers by Yoshiteru Takekita Breakdown of academic impact, for papers by Sean W. Flynn Breakdown of academic impact, for papers by Jeffrey Kraft Breakdown of academic impact, for papers by Christian Landvogt Breakdown of academic impact, for papers by Karuna Jayathilake
Rankless by CCL
2026